Location of COVID-19 vaccine testing facilities in Shanghai, China
- The Food and Drug Administration (FDA) had claimed the name and location of the testing facilities were protected by the confidential commercial information exemption of the Freedom of Information Act (FOIA).
- Judicial Watch obtained the previously redacted documents through a September 2021 FOIA lawsuit filed after the FDA, the Centers for Disease Control and Prevention and the National Institute for Allergy and Infectious Disease failed to respond to a June 7, 2021, FOIA request for all biodistribution studies and data for the vaccines.
In July 2022, National Institutes of Health (NIH) records revealed an FBI “inquiry” into the NIH’s controversial bat coronavirus grant tied to the Wuhan Institute of Virology
- The records also show National Institute of Allergy and Infectious Diseases (NIAID) officials were concerned about “gain-of-function” research in China
- the government emails also reported that the foundation of U.S. billionaire Bill Gates worked closely with the Chinese government to pave the way for Chinese-produced medications to be sold abroad
Other COVID-19 issues uncovered through FOIA:
- In May 2022, the former director of the Galveston National Laboratory at the University of Texas Medical Branch (UTMB) warned Chinese researchers at the Wuhan Institute of Virology of potential investigations into the COVID issue by Congress.
May 2022: HHS records regarding biodistribution studies and related data for the COVID-19 vaccines show a key component of the vaccines developed by Pfizer/BioNTech, lipid nanoparticles (LNPs), were found outside the injection site, mainly the liver, adrenal glands, spleen and ovaries of test animals.
- April 2022: Records from the Federal Select Agent Program (FSAP) reveal safety lapses and violations at U.S. biosafety laboratories that conduct research on dangerous agents and toxins.
https://www.judicialwatch.org/covid-vaccine-studies-conducted-in-china/
No comments:
Post a Comment